Role of sphingolipid-mediated cell death in neurodegenerative diseases

Journal of Lipid Research

Volumn 39, Issue 1, 1998, Pages 1-16

  Ariga, Toshio ^a,b   Jarvis, W David ^c   Yu, Robert K ^b  

^a EISAI CO LTD   (Japan)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Apoptosis; Ceramide; Gangliosides; Glycolipids; Lysosphingolipids; Neurodegenerative disease; Programmed cell death; Sphingoli pids; Sphingomyelin; Sphingosine

Indexed keywords

CERAMIDE; GANGLIOSIDE; SPHINGOMYELIN; SPHINGOSINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; AUTOIMMUNITY; DEMYELINATING NEUROPATHY; GROWTH REGULATION; GUILLAIN BARRE SYNDROME; HUMAN; LIPID METABOLISM; MOTOR NEURON DISEASE; MYELINATION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; GANGLIOSIDES; GLYCOLIPIDS; HUMANS; LIPIDS; NEURODEGENERATIVE DISEASES; SECOND MESSENGER SYSTEMS; SPHINGOLIPIDS;

EID: 0031905956     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Kerr, J. F. R., A. H. Wyllie, and A. R. Currier. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26: 239-257.
2. Gottlieb, R. P., J. Nordbery, E. Skowronski, and R. M. Babior. 1996. Apoptosis induced in Jurkat cells by several agents is preceeded by intracellular acidification. Proc. Natl. Acad. Sci. USA. 93: 654-658.
3. Boudreau, N., C. J. Sympson, Z. Werb, and M. J. Bissell. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267: 891-893.
4. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science. 267: 1445-1449.
5. Fraser, A., and G. Evan. 1996. A license to kill. Cell. 85: 781-784.
6. Hannun, Y. A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science. 274: 1855-1899.
7. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267: 1456-1462.
8. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267: 1449-1456.
9. Enari, M., A. Hase, and S. Nagata. 1995. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14: 5201-5208.
10. Cifone, M. G., R. De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Lanier, A. Santoni, and R. Testi. 1994. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180: 1547-1552.
11. Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kronke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in TNFα signaling. Cell. 78: 1005-1015.
12. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyrikis, A. Haimovitz-Friedman, Z. Fuks, and N. Kolesnick. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380: 75-79.
13. Goldkorn, T., K. A. Dressier, J. Muindi, N. S. Radin, J. Mendelsohn, D. Mendalino, D. C. Liotta, and R. N. Kolesnick. 1991. Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. J. Biol. Chem. 266: 16092-16097.
14. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y. A. Hannun. 1993. Programmed cell death induced by ceramide. Science. 259: 1769-1771.
15. Jarvis, W. D., R. N. Kolesnick, F. A. Fornari, Jr., R. S. Taylor, D. A. Gewirtz, and S. Grant. 1994. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Arad. Sci. USA. 91: 73-77.
16. Jarvis, W. D., F. A. Fornari, Jr., J, L. Browning, D. A. Gewirtz, R. N. Kolesnick, and S. Grant. 1994. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem. 269: 31685-31692.
17. Jarvis, W. D., A. J. Turner, L. F. Povirk, R. S. Taylor, and S. Grant. 1994. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54: 1707-1714.
18. Jarvis, W. D., S. Grant, and R. N. Kolesnick. 1996. Ceramide and the induction of apoptosis. Clin. Cancer Res. 2: 1-6.
19. Jarvis, W. D., F. A. Fornari, Jr., R. S. Traylor, H. A. Martin, L. B. Kramer, R. K. Erukulla, R. Bittman, and S. Grant. 1996. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271: 8275-8284.
20. Jarvis, W. D., F. A. Fornari, Jr., A. J. Freemerman, E. Szabo, M. J. Birrer, C. R. Johnson, S. E. Barbour, K. L. Auer, P. Dent, and S. Grant. Coordinate regulation of stress-activated protein kinase (SAPK) and mitogen-activated protein kinase (MAPK) cascades in the apoptotic actions of ceramide and sphingosine in human myeloid leukemia cells. Mol. Pharmacol. In press.
21. Merrill, A. H., Y. A. Hannun, and R. M. Bell. 1993. Sphingolipids and their metabolites in cell regulation. Adv. Lipid Res. 23: 1-26.
22. Bielawska, A., H. M. Crane, D. Liotta, L. M. Obeid, and Y. A. Hannun. 1993. Selectivity of ceramide-mediated biology. J. Biol. Chem. 268: 26226-26232.
23. Zakhieri, Z., R. R. Lockshin, and R. Bittman. 1996. Stereospecific induction of apoptosis in U937 cells by N-octanoylsphingosine and N-octylsphingosine: the ceramide group is not required for apoptosis. Eur. J. Biochem. 236: 729-737.
24. Cuvillier, O., G. Pirianov, B. Kleuser, P. G. Vanek, O. A. Coso, S. Gutkind, and S. Spiegel. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381: 800-803.
25. Raines, M., R. N. Kolesnick, and D. W. Golde. 1993. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268: 14572-14575.
26. Joseph, C. K., H. S. Byun, R. Bittman, and R. N. Kolesnick. 1993. Substrate recognition by ceramide-activated protein kinase: evidence that kinase activity is proline-directed. J. Biol. Chem. 268: 20002-20006.
27. Liu, J., S. Mathias, Z. Yang, and R. N. Kolesnick. 1994. Renaturation and TNFα stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269: 3047-3052.
28. Mathias, S., A. Younes, C-C. Kan, I. Orlow, C. Joseph, and R. N. Kolesnick. 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science. 259: 519-522.
29. Zhang, Y., B. Yao, S. Delikat, S. Bayoumy, X-H. Lin, S. Basil, M. McGinley, P-Y. Chan Hui, H. Lichenstein, and R. N. Kolesnick. 1997. Kinase suppressor of ras is ceramide-activated protein kinase. Cell. 89: 63-72.
30. Yao, B., Y. Zhang, S. Delikat, S. Mathias, S. Basu, and R. N. Kolesnick. 1995. Phosphorylation of Raf by ceramide-activated protein kinase. Nature. 378: 307-310.
31. Huwiler, A., J. Brunner, R. Hummel, M. Vervooddeldonk, S. Dtabels, H. van den Bosch, and J. Pfeilshifter. 1996. Ceramide-binding and activation defines c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA. 93: 6959-6965.
32. Palombella, V. J., and J. Vilček. 1989. Mitogenic and cytotoxic actions of TNF in BALB/c 3T3 cells: role of phospholipase activation. J. Biol. Chem. 264: 18128-18136.
33. 2 is crucial to the cytotoxic of tumor necrosis factor-α. J. Biol. Chem. 268: 11290-11295.
34. 2 is phosphorylated and activated by MAPK. Cell. 72: 269-278.
35. Westwick, J. K., C. Weitzel, A. Minden, M. Karin, and B. A. Brenner. 1994. Tumor necrosis factor-α stimulates AP-1 activity through prolonged activation of c-Jun kinase. J. Biol. Chem. 269: 26396-26401.
36. Westwick, J. K., A. E. Bielawska, G. S. Dbaibo, Y. A. Hannun, and D. A. Brenner. 1995. Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270: 22689-22692.
37. Sawai, H., T. Okazaki, H. Yamamoto, H. Okano, Y. Takeda, M. Tashima, H. Sawada, M. Okuma, H. Ishikura, H. Umehara, and N. Domae. 1995. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol. Chem. 270: 27326-27331.
38. Dobrowsky, R. T., and Y. A. Hannun. 1992. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267: 5048-5051.
39. 2. J. Biol. Chem. 268: 15523-15530.
40. Lee, J. Y., and Y. A. Hannun. 1996. Ceramide inactivates cellular cPKCα. J. Biol. Chem. 271: 13169-13174.
41. Lozano, J., E. Berra, M. M. Municio, M. F. Diaz-Meco, I. Dominguez, L. Sanz, and J. Moscat. 1994. Protein kinase C-ζ is critical for NF-κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269: 19200-19202.
42. Muller, G., M. Ayoub, P. Storz, J. Rennecke, P. Fabbro, and K. Pfizenmaier. 1995. Protein kinase C-ζ is a molecular switch in signal transduction of TNFα, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14: 1961-1969.
43. Gulbins, E., M. Coggeshall, G. Baier, D. Telford, C. Langlet, G. Baier-Bitterlich, N. Bonnefoy-Berard, P. Burn, A. Wittinghofer, and A. Altman. 1994. Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol diesters and diglyceride. Mol. Cell. Biol. 14: 4749-4758.
44. Hannun, Y. A., and R. M. Bell. 1989. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 243: 500-507.
45. Hannun, Y. A., and R. M. Bell. 1987. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science. 235: 670-674.
46. Ohta, H., Y. Yatomi, E. Sweeney, S-i. Hakomori, and Y. Igarashi. 1994. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-α in human neutrophils. FEBS Lett. 355: 267-270.
47. Krown, K. A., M. T. Page, C. Nguyun, D. Zechner, V. Gutierrez, K. L. Comstock, C. C. Glembotski, P. J. Quintana, and R. A. Sabbadini. 1996. TNFα-induced apoptosis in cardiac myocytes: involvement of sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98: 2854-2865.
48. Chmura, S. J., E. Nodzenski, M. A. Crane, S. Virudachalam, D. E. Hallahan, R. R. Weichselbaum, and J. Quintans. 1996. Cross-talk between ceramide and protein kinase C in the control of apoptosis in WEHI-231. Adv. Exp. Med. Biol. 406: 39-55.
49. Hakomori, S-I. 1990. Bifunctional role of glycosphingolipids. J. Biol. Chem. 265: 18713-18716.
50. Ohta, H., E. A. Sweeny, A. Masamune, Y. Yatomi, S-I. Hakomori, and Y. Igarashi. 1995. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DAN fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55: 691-697.
51. Sweeney, E. A., C. Sakakura, T. Shirahama, A. Masamune, H. Ohta, S-I. Hakomori, and Y. Igarashi. 1996. Sphingosine and its methylated derivatives, N,N-dimethylsphingosine (DMS), induce apoptosis in a variety of human cancer cell lines. Int. J. Cancer. 66: 358-366.
52. MacFarlane, D. E., and P. S. O'Donnell. 1993. Phorbol ester induces apoptosis in HL-60 pro-myelocytic leukemia cells but not the PET HL-60 mutant. Leukemia. 7: 1846-1851.
53. Pushkareva, M., W. A. Khan, A. V. Alessenko, N. Sahyoun, and Y. A. Hannun. 1992. Sphingosine activation of protein kinases in Jurkat T cells. J. Biol. Chem. 267: 15246-15251.
54. Pushkareva, M. Y., A. E. Bielawska, D. C. Liotta, and Y. A. Hannun. 1993. Regulation of sphingosine-activated protein kinases: selectivity of activator by sphingosine bases and inhibition by nonesterified fatty acids. Biochem. J. 294: 699-703.
55. Igarashi, Y., S-I. Hakomori, T. Togokuni, B. Dean, S. Fujita, M. Sugimoto, T. Ogawa, K. el-Ghendy, and E. Racker. 1989. Effect of chemically well defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry. 28: 6786-6800.
56. Jefferson, A. B., and H. Schulman. 1988. Sphingosine inhibits calmodulin-dependent enzymes. J. Biol. Chem. 263: 15241-15244.
57. Chao, R., W. A. Khan, and Y. A. Hannun. 1992. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. J. Biol. Chem. 267: 23459-23462.
58. Ohta, H., E. A. Sweeney, A. Masamune, Y. Yatomi, S-I. Hakomori, and Y. Igarashi. 1995. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55: 691-697.
59. Pushkareva, M. Y., R. Chao, A. E. Bielawska, A. H. Merrill, Jr., H. M. Crane, B. Lagu, D. C. Liotta, and Y. A. Hannun. 1995. Stereoselectivity of induction of the retinoblastoma gene product (pRB) dephosphorylation by D-erythro-sphingosine supports a role for pRb in growth suppression by sphingosine. Biochemistry. 34: 1885-1892.
60. Brindley, D. N., A. Abousalham, Y. Kikuchi, C. N. Wang, and D. W. Waggoner. 1996. Crosstalk between bioactive glycerolipids and sphingolipids in signal transduction. Biochem. Cell Biol. 74: 469-476.
61. Gomez-Munoz, A., A. Martin, L. O'Brien, and D. N. Brindley. 1994. Cell-permeable ceramides inhibit the stimulation of DNA synthesis activity by phosphatidate and lysophosphatidate in rat fibroblasts. J. Biol. Chem. 269: 8937-8943.
62. Gomez-Munoz, A., D. W. Waggoner, L. O'Brien, and D. N. Brindley. 1995. Interaction of ceramide, sphingosine, and sphingosine-1-phosphate in the regulation of DNA synthesis. J. Biol. Chem. 270: 26318-26385.
63. Wu, J., S. Spiegel, and T. W. Sturgill. 1995. Sphingosine-1-phosphate rapidly activates the mitogen-activated protein kinase pathway. J. Biol. Chem. 270: 11484-11489.
64. Stone, R. M., B. L. Weber, D. R. Spriggs, and D. W. Kufe. 1988. Phospholipase C activates protein kinase C and induces monocytic differentiation in HL-60 cells. Blood. 72: 739-744.
65. Jarvis, W. D., L. F. Povirk, A. J. Turner, R. S. Traylor, D. A. Gewirtz, G. R. Pettit, and S. Grant. 1994. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem. Pharmacol. 47: 839-852.
66. Haimovtz-Fiedman, A., C-C. Kan, D. Ehleiter, R. S. Persaud, M. McLoughlin, Z. Fuks, and R. N. Kolesnick. 1994. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180: 525-535.
67. Sakakura, C., E. A. Sweeney, T. Shirahama, F. Ruan, F. Solca, M. Kohno, S-I. Hakomori, and Y. Igarashi. 1997. Inhibition of MAPK by sphingosine and its methylated derivative. N,N-dimethylsphingosine: a correlation with induction of apoptosis in solid tumor cells. Int. J. Oncol. 11: 31-39.
68. Suzuki, K. 1998. Twenty-five years of the "psychosine hypothesis." Neurochem. Res. In press.
69. Yu, R. K., T. Ariga, H. Yoshino, S. Ren, and R. Katoh-Semba. 1994. Differential effects of glycosphingolipids on protein kinase C activities in PC12D pheochromocytoma cells. J. Biomed. Sci. 1: 229-236.
70. Joseph, C. K., S. D. Wright, W. G. Bornmann, J. T. Randolph, E. Ravi Kumar, R. Bittman, J. Liu, and R. N. Kolesnick. 1994. Bacterial liposaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269: 17606-17610.
71. Wright, S. D., and R. N. Kolesnick. 1995. Does endotoxin stimulate cells by mimicking ceramide? Immunol. Today. 16: 297-302.
72. Yasugi, E., Y. Yokoyama, Y. Seyama, K. Kano, Y. Hayashi, and M. Oshima. 1995. Dolichyl phosphate, a potent inducer of apoptosis in rat glioma C6 cells. Biochem. Biophys. Res. Commun. 216: 848-853.
73. Dohi, T., E. Yasugi, and M. Oshima. 1996. Activation of mitogen-activated protein kinase in dolichyl phosphate-induced apoptosis in U937 cells. Biochem. Biophys. Res. Commun. 224: 87-91.
74. Moore, K. J., and G. Matlashewski. 1994. Intracellular infection by Leishmania denovani inhibits macrophage apoptosis. J. Immunol. 152: 2930-2937.
75. Jayadev, S., C. M. Linardic, and Y. A. Hannun. 1994. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor-α. J. Biol. Chem. 269: 5757-5763.
76. Wong, G. H. W., J. H. Elwell, L. W. Oberley, and D. V. Goeddel. 1989. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58: 923-931.
77. Reynolds, E. S., M. F. Kanz, P. Chieco, and M. T. Moslen. 1984. 1,1-Dichloroethylene: apoptotic hepatotoxin? Environ. Health Perspect. 57: 313-320.
78. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216.
79. Verhoven, B., R. A. Schlegel, and P. Williamson. 1995. Mechanisms of phosphatidyiserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182: 1597-1601.
80. Duncan, D. D., and D. A. Lawrence. 1991. Residual activation events functional after irradiation of mouse splenic lymphocytes. Radiat. Res. 125: 6-13.
81. Diomede, L., B. Piovani, F. Re, P. Principe, F. Colotta, E. J. Modest, and M. Salmona. 1994. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int. J. Cancer. 57: 645-649.
82. Sandstrom, P. A., P. W. Tebbey, S. Van Cleave, and T. M. Buttke. 1994. Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathion peroxidase deficiency. J. Biol. Chem. 269: 798-801.
83. Corbeil, J., E. Rapaport, D. D. Richman, and D. J. Looney. 1994. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. J. Clin. Invest. 93: 1981-1986.
84. Lauener, R., Y. Shen, V. Duronio, and H. Salari. 1995. Selective inhibition of phosphatidylinositol 3-kinase by phosphatidic acid and related lipids. Biochem. Biophys. Res. Commun. 215: 8-14.
85. Hakomori, S-I. 1994. Control by glycosphingolipids of cell growth, cell adhesion, and transmembrane signalling. In Glycobiology of the Brain. M. Nicolini and P. F. Zatta, editors. Pergamon Press, NY. 83-95.
86. Ferrari, G., B. L. Anderson, R. M. Stephens, D. R. Kaplan, and L. A. Greene. 1995. Prevention of apoptotic neuronal death by GM1 ganglioside. J. Biol. Chem. 270: 3074-3080.
87. Farooqui, T., T. Franklin, D. K. Pearl, and A. J. Yates. 1997. Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA. J. Neurochem. 68: 2348-2355.
88. Mutoh, T., A. Tokuda, T. Miyada, M. Hamaguchi, and N. Fugiki. 1995. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl. Acad. Sci. USA. 92: 5087-5091.
89. Yu, R. K., J. R. Goldenring, J. Y. H. Kim, and R. J. DeLorenzo. 1986. Gangliosides as differential modulators of membrane-bound protein kinase systems. In Neuronal Plasticity and Gangliosides. G. Tettamanti, R. W. Ledeen, Y. Nagai, K. Sandhoff, and G. Toffano, editors. Liviana Press, Padova. 95-104.
90. Yu, R. K. 1988. Regulation of protein phosphorylation by gangliosides. In New Trends in Ganglioside Research. Neurochemical and Neurodegenerative Aspects. R. W. Ledeen, E. Hogan, R. K. Yu, A. Yates, and G. Tettamanti, editors. Liviana Press, Padova. 461-471.
91. Mangeney, M., Y. Richard, D. Coulaud, T. Tursz, and J. Wiels. 1991. CD77: an antigen of germinal center B cells entering apoptosis. Eur. J. Immunol. 21: 1131-1140.
92. Ohsawa, T., T. Miyatake, and N. Yuki. 1993. Anti-b-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons. Neurosci. Lett. 157: 167-170.
93. Koike, T., K. Fehsel, J. Zielasek, H. Kolb, and V. Burkart. 1993. Gangliosides protect from TNF-α-induced apoptosis. Immunol. Lett. 35: 207-212.
94. Saito, M., and M. Saito. 1996. Effects of gangliosides on cell death and differentiation in rat Schwanoma cells. J. Neurochem. 66 (Suppl.): S37A.
95. Raff, M., B. Barres, J. Burne, H. Coles, Y. Ishizaki, and M. Jacobson. 1993. Programmed cell death and the control of cell survival lessons from the nervous system. Science. 262: 695-700.
96. Wiesner, D. A., and G. Dawson. 1996. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66: 1418-1425.
97. Louis, J-C., E. Magal, S. Takayama, and S. Varon. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 29: 689-692.
98. Masu, Y., E. Wolf, B. Holtmann, M. Sendtner, G. Berm, and H. Thoenen. 1993. Disruption of the CNTF gene results in motor neuron degeneration. Nature. 365: 27-32.
99. Prakas-Kramarski, R., R. Eilam, O. Spiegler, S. Livi, N. Liu, D. Chang, D. Wen, M. Schwartz, and Y. Yarden. 1994. Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc. Natl. Acad. Sci. USA. 91: 9387-9391.
100. Mitsumoto, H., K. Ikeda, B. Klinkosz, J. M. Cedarbaum, V. Wong, and R. M. Lindsay. 1994. Arrest of motoneuron disease in wobbler mice cotreated with CNTF and BDNF. Science. 265: 1107-1110.
101. Stahl, N., T. G. Boulton, T. Farruggella, N. Ip, S. Davis, B. A. Witthuhn, F. W. Quelle, O. Silvennoinen, G. Barbieri, S. Pellegrini, J. N. Ihle, and G. D. Yancopoulos. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science. 263: 92-95.
102. Kessler, J., W. H. Ludlam, M. M. Freidin, D. H. Hall, M. D. Michaelson, D. C. Spray, M. Dougherty, and D. K. Batter. 1993. Cytokine-induced programmed death of cultured sympathetic neurons. Neuron. 11: 1123-1132.
103. Kubo, T., T. Nonomura, Y. Enokido, and H. Hatanaka. 1995. Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture. Dev. Brain Res. 85: 249-258.
104. Itoh, A., and K. Horigome. 1995. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J. Neurochem. 65: 463-466.
105. Hannun, Y. A., and L. M. Obeid. 1995. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20: 73-77.
106. Mayer, M., and M. Noble. 1994. N-Acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc. Natl. Acad. Sci. USA. 91: 7496-7500.
107. Dobrowsky, R. T., G. M. Jenkins, and Y. A. Hannun. 1995. Neurotrophins induce sphingomyelin hydrolysis. J. Biol. Chem. 270: 22135-22141.
108. NTR with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J. Biol. Chem. 272: 10922-10927.
109. Katzman, R., and L. F. Thai. 1989. Neurochemistry of Alzheimer's disease. In Basic Neurochemistry. G. J. Siegel, B. W. Agranoff, R. W. Albers, and P. B. Molinoff, editors. 4th ed. Raven Press, New York. 827-838.
110. Selkoe, D. L. 1994. Cell biology of the amyloid β protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10: 373-403.
111. Ihara, Y. 1988. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459: 138-144.
112. Mori, H., Y. Hamada, T. Kawaguchi, T. Honda, J. Kondo, and Y. Ihara. 1989. A distinct form of tau is selectively incorporated into Alzheimer's paired helical filaments. Biochem. Biophys. Res. Commun. 159: 1221-1226.
113. Wolozin, B. L., A. Scicutta, and P. Davies. 1988. Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer's disease. Prof. Natl. Acad. Sci. USA. 85: 6202-6206.
114. Emory, C. R., T. A. Ala, and W. H. Frey. 1987. Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles. Neurology. 37: 768-772.
115. Mattson, M. P., B. Cheng, D. Davis, K. Bryant, I. Leibenburg, and R. E. Rydel. 1992. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12: 376-389.
116. Pike, C. J., A. J. Walencewicz, C. G. Glabe, and C. W. Cotman. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563: 311-314.
117. Selkoe, D. L. 1996. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271: 18295-18298.
118. Loo, D., A. Copani, C. Pike, E. Whuemore, A. Walencewicz, and C. Cotman. 1993. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90: 7951-7955.
119. Ko, L., K. R. Sheu, O. Young, H. Thaler, and J. P. Blass. 1990. Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease. Am. J. Pathol. 136: 867-879.
120. Nuydens, R., M. De Jong, R. Nuyens, F. Cornelissen, and H. Geerts. 1995. Moderate kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity. Neurobiol. Aging. 16: 465-477.
121. Nuydens, R., C. Heers, A. Chadarevian, M. De Jong, R. Nuyens, F. Cornelissen, and H. Geerts. 1995. Sodium butyrate induces abberrant tau phosphorylation and programmed cell death in human neuroblastoma cells. Brain Res. 688: 86-94.
122. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 271: 521-525.
123. Behl, C., J. Davis, G. M. Cole, and D. Schubert. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186: 944-950.
124. Pike, C. J., P. J. Vaughan, D. D. Cunningham, and C. W. Cotman. 1996. Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J. Neurochem. 66: 1374-1382.
125. Yamanishi, Y., H. Ogura, T. Kosasa, S. Araki, Y. Sawa, and Y. Yamatsu. 1991. Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase: comparison with other inhibitors. In Basic Clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases. Plenum Press, New York. 409-413.
126. Emory, C. R., T. A. Ala, and W. H. Frey. 1987. Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles. Neurology. 37: 768-772.
127. Tooyama, I., T. Yamada, S. U. Kim, and P. L. McGeer. 1992. Immunohistochemical study of A2B5-positive ganglioside in postmortem human brain tissue of Alzheimer disease, amyotrophic lateral sclerosis, progressive supranuclear palsy and control cases. Neurosci. Lett. 136: 91-94.
128. Kasai, N., and R. K. Yu. 1983. The monoclonal antibody A2B5 is specific to ganglioside GQ1c. Brain Res. 277: 155-158.
129. Dubois, C., J-C. Manuguerra, B. Hauttecoeur, and J. Maze. 1990. Monoclonal antibody A2B5, which detects cell surface antigens, bind to ganglioside GT3 (II3 (NeuAc)3LacCer) and its 9-O-acetyl derivative. J. Biol. Chem. 265: 2797-2803.
130. Hirabayashi, Y., M. Hirota, M. Matsumoto, H. Tanaka, K. Obata, and S. Ando. 1988. Developmental changes of c-series polysialogangliosides in chick brains revealed by mouse monoclonal antibodies M6704 and M7103 with different epitope specificities. J. Biochem. 104: 973-979.
131. Rosner, H., and H. Rahmann. 1987. Ontogeny of vertebrate brain gangliosides. In Gangliosides and Modulation of Neuronal Functions. H. Rahmann, editor. Nato ASI Series. Vol. H7. 373-390.
132. Crino, P. B., M. D. Ullman, B. A. Vogt, E. D. Bird, and L. Volicer. 1989. Brain gangliosides in dementia of Alzheimer's type. Arch Neurol. 46: 398-401.
133. Kracun, I., S. Kalanj, J. Talan-Hranilovic, and C. Cosovic. 1992. Cortical distribution of gangliosides in Alzheimer's disease. Neurochem. Int. 20: 433-438.
134. Takahashi, H., K. Hirokawa, S. Ando, and K. Obata. 1991. Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens. C-series gangliosides and microtubule-associated protein 5. Acta Neuropathol. 81: 626-631.
135. Majocha, R. E., F. B. Jungalwala, A. Rodenrys, and C. A. Marotta. 1989. Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides. J. Neurochem. 53: 953-961.
136. Svennerholm, L., C. G. Gottfries, K. Blennow, P. Fredman, I. Karlsson, J-E. Mansson, G. Toffano, and A. Wallin. 1990. Parenteral administration of GM1 ganglioside to presenile Alzheimer patients. Acta Neurol. Scand. 81: 48-53.
137. Svennerholm, L. 1994. Gangliosides - a new therapeutic agent against stroke and Alzheimer's disease. Life Sci. 55: 2125-2134.
138. Ledeen, R. W. 1989. Biosynthesis, metabolism, and biological effects of gangliosides. In Neurobiology and Glycoconjugates. R. U. Margolis and R. K. Margolis, editors. Plenum Press, New York. 43-83.
139. Yanagisawa, K., A. Odaka, N. Suzuki, and Y. Ihara. 1995. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature Med. 1: 1062-1066.
140. Parton, R. G. 1994. Ultrastructural localization of gangliosides: GM1 is concentrated in caveola. J. Histochem. Cytochem. 42: 155-166.
141. Sherrington, R., E. L. Rogaev, Y. Liang, E. A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, T. Tsuda, L. Mar, J-F. Foncin, A. C. Bruni, M. P. Montesi, S. Sorbi, I. Rainero, L. Pinessi, L. Nee, I. Chumakov, D. Pollen, A. Brookes, P. Sanseau, R. J. Polinski, W. Wasco, H. A. R. DaSilva, J. L. Haines, M. A. Pericak-Vance, R. E. Tanzi, A. D. Roses, P. E. Fraser, J. M. Rommens, and P. H. St. George-Hyslop. 1995. Cloning of a gene bearing mis-sense mutations in early onset familial Alzheimer's disease. Nature. 375: 754-760.
142. Nishinaka, T., D. Iwata, S. Shimada, K. Koska, and Y. Suzuki. 1993. Anti-ganglioside GD1a monoclonal antibody recognizes senile plaques in the brains of patients with Alzheimer-type dementia. Neurosci. Res. 17: 171-176.
143. Blennow, K., P. Davidsson, A. Wallin, P. Fredman, C. G. Gottfries, J. E. Masson, and L. Svennerholm. 1992. Differences in cerebrospinal fluid gangliosides between 'probable Alzheimer's disease' and normal aging. Aging. 4: 301-306.
144. Boka, G., P. Anglade, D. Wallach, F. Javoy-Agid, M. R. Payne, and E. C. Hirsch. 1994. Receptor-mediated action of tumor necrosis factor in Parkinson's disease? Neurosci. Lett. 172: 151-154.
145. Brugg, B., P. P. Michel, Y. Agid, and M. Ruberg. 1996. Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66: 733-739.
146. Kordower, J. H., V. Charles, R. Bayer, R. T. Bartus, S. Putney, L. E. Walus, and P. M. Friden. 1994. Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proc. Natl. Acad. Sci. USA. 91: 9077-9080.
147. Friden, P. M., L. R. Walus, P. Watson, S. R. Doctrow, J. W. Kozarich, C. Backman, H. Bergman, B. Hoffer, F. Bloom, and A-C. Granholm. 1993. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science. 259: 373-377.
148. Zurn, A. D., E. E. Baetge, J. P. Hammang, S. A. Tan, and P. Aebischer. 1994. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurons. Neuroreport. 6: 113-118.
149. Massague, J. 1996. Crossing receptor boundaries. Nature. 382: 29-30.
150. Trupp, M., E. Arenas, M. Fainzilber, A-S. Nilsson, B-A. Sieber, M. Grigoriou, C. Kilkenny, E. Salazar-Grueso, V. Pachnis, U. Arumae, H. Sariola, M. Saarma, and C. F. Ibanez. 1996. Functional receptor for GDNF encoded by the c-ret pro-oncogene. Nature. 381: 785-789.
151. Durbec, P., C. V. Marcos-Gutierrez, C. Kolkenny, M. Grigoriou, K. Wartiowaara, P. Suvanto, D. Smith, B. Ponder, F. Costantini, M. Saarma, H. Sariola, and V. Pachnis. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 381: 789-793.
152. Yu, R. K., H. Yoshino, and T. Ariga. 1993. The role of glycosphingolipids in peripheral neuropathies and related disorders. In Glycobiology of the Brain. M. Nicolini and P. F. Zata, editors. Pergamon Press, New York. 151-173.
153. Obi, T., S. Kusunoki, M. Takatsu, K. Mizoguchi, and Y. Nishimura. 1992. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol. Scand. 86: 215-218.
154. Willison, H. J., G. M. O'Hanlon, G. Paterson, J. Veitch, G. Wilson, M. Roberts, and T. Tang. 1996. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice encoded by the variable region heavy chain gene, V1-18. J. Clin. Invest. 97: 1155-1164.
155. Kanda, T., H. Yoshino, T. Ariga, M. Yamawaki, and R. K. Yu. 1994. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J. Cell Biol. 126: 235-246.
156. Ariga, T., T. Kohoriyama, L. Freddo, N. Latov, M. Saito, K. Kon, S. Ando, M. Suzuki, M. E. Hemling, K. L. Rinehart, S. Kusunoki, and R. K. Yu. 1987. Characterization of sulfate glucuronic acid-containing glycolipids reacting with IgM-M proteins in patients with neuropathy. J. Biol. Chem. 262: 848-853.
157. Chou, D. K. H., A. A. Ilyas, J. E. Evans, C. Costello, R. H. Quarles, and F. B. Jungalwala. 1986. Structure of sulfated glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J. Biol. Chem. 261: 11717-11725.
158. Latov, N., A. P. Hays, P. D. Donofrio, H. Liao, H. Ito, S. McGinnis, K. Manoussos, L. Freddo, M. E. Shy, H. Sherman, W. Chang, H. S. Greenberg, J. W. Albers, A. G. Alessi, D. Keren, R. K. Yu, L. P. Rowland, and E. A. Kabat. 1988. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology. 38: 763-768.
159. Pestronk, K., D. T. Cornblath, A. A. Ilyas, H. Baba, R. H. Quarles, J. W. Griffin, K. Alderson, and R. N. Adams. 1988. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24: 73-78.
160. Yuki, N., H. Yoshino, S. Sato, and T. Miyatake. 1990. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobactor enteritis. Neurology. 40: 1900-1902.